Skip to main content
UniHealth

Doctor search

Eric J Yang, MD

Pathology · Stanford

NPI 1932457264

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
15 years
Tufts University School of Medicine, 2011

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yang’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A136668 · Current

Licensed to practise in California · since 2015 · expires 2028-09-30 · Tufts University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Pathology - Cytopathology
  • American Board of Pathology - Pathology – Anatomic

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$62,778

Medicare paid this office $62,778 for 475 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Pathology examination of tissue using a microscope, intermediate complexity229$11,228$33
Special stained specimen slides to examine tissue, each additional procedure82$9,186$25
Evaluation of fine needle aspirate with interpretation and report89$8,398$63
Pathology examination of tissue using a microscope, moderately high complexity40$5,602$72
Cell examination of specimen, selective cellular enhancement technique182$4,586$24
See all 17 services
Every Original Medicare service billed
Pathology examination of tissue using a microscope, intermediate complexity229$11,228$33
Special stained specimen slides to examine tissue, each additional procedure82$9,186$25
Evaluation of fine needle aspirate with interpretation and report89$8,398$63
Pathology examination of tissue using a microscope, moderately high complexity40$5,602$72
Cell examination of specimen, selective cellular enhancement technique182$4,586$24
Pathology examination of tissue using a microscope, high complexity24$4,434$130
Special stained specimen slides to examine tissue, initial procedure107$3,834$31
Microscopic genetic analysis of tumor, manual44$2,721$37
Pathology examination of specimen during surgery, first tissue block22$2,298$56
Evaluation of fine needle aspirate59$2,078$32
Surgical pathology consultation and report on referred slides prepared elsewhere28$1,993$71
Fine needle aspiration biopsy using ultrasound guidance, first growth18$1,090$61
Genetic sequencing localization, initial procedure25$923$37
Surgical pathology consultation and report on referred material requiring preparation of slides11$872$79
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode22$690$20
Cell examination of specimen, concentration technique12$223$19
Pathology examination of tissue using a microscope, moderately low complexity11$143$10

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Fine needle aspiration biopsy using ultrasound guidance, first growth32–3017–18
Fine needle aspiration biopsy, first growth22–––––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

475 Original Medicare patients in 2024. Average age 73 · Under 65 9% · 85 and older 8% · Women 60% · Also on Medicaid 26% · Health risk score 1.60. Above the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 71% · Cancer 36% · Diabetes 32% · Coronary heart disease 29% · Chronic kidney disease 27% · Atrial fibrillation 22% · Heart failure 21% · Depression 19% · COPD 17% · Stroke 9% · Dementia 7%.

The office billed $874,073, Medicare allowed $79,719 and paid $62,778; for 1,667 services of 32 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244751,667731.60$874,073$62,778
2023261962721.33$449,441$39,750
20223641,467721.62$553,920$59,650
20215782,301731.64$675,610$93,551
20203351,366721.68$363,370$60,496
20195931,900721.82$578,442$76,830
20186091,882731.77$504,686$76,284
20176592,051721.78$528,948$86,177
20165671,548731.74$415,375$63,913
2015147329711.58$77,310$14,306

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Pathology examination of tissue using a microscope, intermediate complexity142$8,500$34
Special stained specimen slides to examine tissue, each additional procedure46$5,369$26
Pathology examination of tissue using a microscope, moderately high complexity28$4,761$77
Pathology examination of tissue using a microscope, high complexity24$3,401$136
Evaluation of fine needle aspirate with interpretation and report35$3,322$64
Pathology examination of specimen during surgery, first tissue block26$2,738$58
Special stained specimen slides to examine tissue, initial procedure65$2,271$32
Microscopic genetic analysis of tumor, manual30$1,980$39
Surgical pathology consultation and report on referred slides prepared elsewhere22$1,714$75
Cell examination of specimen, selective cellular enhancement technique55$1,381$24
Evaluation of fine needle aspirate22$722$31
Genetic sequencing localization, initial procedure12$482$40

2022: 14 services

Original Medicare services billed in 2022
Pathology examination of tissue using a microscope, intermediate complexity226$13,191$34
Special stained specimen slides to examine tissue, each additional procedure70$8,377$26
Evaluation of fine needle aspirate with interpretation and report93$8,317$65
Pathology examination of tissue using a microscope, moderately high complexity33$5,887$77
Pathology examination of tissue using a microscope, high complexity26$5,183$136
Special stained specimen slides to examine tissue, initial procedure105$3,702$32
Evaluation of fine needle aspirate66$2,562$33
Microscopic genetic analysis of tumor, manual34$2,262$39
Cell examination of specimen, selective cellular enhancement technique87$2,250$26
Surgical pathology consultation and report on referred slides prepared elsewhere22$1,643$75
Pathology examination of specimen during surgery, first tissue block14$1,290$59
Fine needle aspiration biopsy using ultrasound guidance, first growth17$1,134$67
Genetic sequencing localization, initial procedure24$977$39
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode17$533$21

2021: 19 services

Original Medicare services billed in 2021
Pathology examination of tissue using a microscope, intermediate complexity324$17,804$35
Evaluation of fine needle aspirate with interpretation and report173$16,526$67
Special stained specimen slides to examine tissue, each additional procedure114$12,117$27
Pathology examination of tissue using a microscope, moderately high complexity38$6,739$79
Evaluation of fine needle aspirate141$6,385$34
Special stained specimen slides to examine tissue, initial procedure155$5,786$33
Cell examination of specimen, selective cellular enhancement technique180$4,741$25
Microscopic genetic analysis of tumor, manual49$3,645$40
Surgical pathology consultation and report on referred slides prepared elsewhere43$3,403$77
Pathology examination of tissue using a microscope, high complexity24$3,365$140
Pathology examination of specimen during surgery, first tissue block17$2,207$60
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure22$2,050$60
Fine needle aspiration biopsy using ultrasound guidance, first growth30$1,992$66
Special stained specimen slides to identify organisms including interpretation and report23$1,117$25
Genetic sequencing localization, initial procedure24$1,037$40
Flow cytometry technique for dna or cell analysis, 16 or more markers13$1,027$79
Surgical pathology consultation and report on referred material requiring preparation of slides12$991$83
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode31$941$21
Cell examination of specimen, concentration technique15$323$22

2020: 14 services

Original Medicare services billed in 2020
Pathology examination of tissue using a microscope, intermediate complexity199$11,700$37
Evaluation of fine needle aspirate with interpretation and report107$8,616$68
Special stained specimen slides to examine tissue, each additional procedure73$8,491$28
Pathology examination of tissue using a microscope, moderately high complexity28$7,268$83
Special stained specimen slides to examine tissue, initial procedure91$3,610$34
Microscopic genetic analysis of tumor, manual46$3,354$41
Pathology examination of tissue using a microscope, high complexity22$3,200$145
Surgical pathology consultation and report on referred slides prepared elsewhere33$2,691$82
Pathology examination of specimen during surgery, first tissue block19$2,467$63
Cell examination of specimen, selective cellular enhancement technique62$1,647$26
Evaluation of fine needle aspirate37$1,351$36
Flow cytometry technique for dna or cell analysis, 16 or more markers15$1,308$82
Special stained specimen slides to identify organisms including interpretation and report12$570$26
Genetic sequencing localization, initial procedure11$558$43

2019: 19 services

Original Medicare services billed in 2019
Evaluation of fine needle aspirate with interpretation and report180$16,474$66
Pathology examination of tissue using a microscope, intermediate complexity275$13,585$36
Special stained specimen slides to examine tissue, each additional procedure98$9,602$28
Cell examination of specimen, selective cellular enhancement technique240$6,650$26
Special stained specimen slides to examine tissue, initial procedure129$4,896$34
Surgical pathology consultation and report on referred slides prepared elsewhere49$3,795$77
Microscopic genetic analysis of tumor, manual57$3,531$41
Evaluation of fine needle aspirate79$2,833$33
Pathology examination of tissue using a microscope, moderately high complexity18$2,804$80
Fine needle aspiration biopsy using ultrasound guidance, first growth30$2,113$66
Pathology examination of tissue using a microscope, high complexity12$1,842$142
Surgical pathology consultation and report on referred material requiring preparation of slides14$1,164$83
Fine needle aspiration biopsy, first growth22$1,063$48
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure12$972$61
Special stained specimen slides to identify organisms including interpretation and report24$890$25
Flow cytometry technique for dna or cell analysis, 9 to 15 markers11$653$59
Genetic sequencing localization, initial procedure14$587$42
Cell examination of specimen, concentration technique16$345$22
Special stained specimen slides to examine tissue including interpretation and report12$206$11

2018: 18 services

Original Medicare services billed in 2018
Evaluation of fine needle aspirate with interpretation and report228$19,638$67
Pathology examination of tissue using a microscope, intermediate complexity285$13,693$36
Special stained specimen slides to examine tissue, each additional procedure97$8,965$27
Cell examination of specimen, selective cellular enhancement technique227$6,611$26
Special stained specimen slides to examine tissue, initial procedure130$4,874$34
Surgical pathology consultation and report on referred slides prepared elsewhere55$4,344$79
Evaluation of fine needle aspirate85$3,181$34
Microscopic genetic analysis of tumor, manual33$2,473$43
Fine needle aspiration using imaging guidance28$1,861$58
Flow cytometry technique for dna or cell analysis, 16 or more markers15$1,188$79
Fine needle aspiration biopsy, first growth19$1,172$59
Surgical pathology consultation and report on referred material requiring preparation of slides14$1,110$79
Special stained specimen slides to identify organisms including interpretation and report21$991$25
Ultrasonic guidance for needle placement24$693$29
Genetic sequencing localization, initial procedure15$630$42
Cell examination of specimen, concentration technique15$388$22
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening12$376$31
Special stained specimen slides to examine tissue including interpretation and report12$203$11

2017: 22 services

Original Medicare services billed in 2017
Evaluation of fine needle aspirate with interpretation and report225$18,413$66
Pathology examination of tissue using a microscope, intermediate complexity313$15,959$36
Special stained specimen slides to examine tissue, each additional procedure92$7,672$27
Cell examination of specimen, selective cellular enhancement technique222$6,155$25
Pathology examination of tissue using a microscope, moderately high complexity23$5,535$80
Surgical pathology consultation and report on referred slides prepared elsewhere63$5,070$79
Special stained specimen slides to examine tissue, initial procedure117$4,560$34
Evaluation of fine needle aspirate117$4,257$34
Microscopic genetic analysis of tumor, manual29$2,812$52
Pathology examination of tissue using a microscope, high complexity14$2,270$142
Fine needle aspiration using imaging guidance31$2,166$59
Pathology examination of specimen during surgery, first tissue block16$1,929$60
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure14$1,493$60
Fine needle aspiration biopsy, first growth21$1,299$62
Special stained specimen slides to identify organisms including interpretation and report30$1,235$26
Surgical pathology consultation and report on referred material requiring preparation of slides13$1,061$82
Ultrasonic guidance for needle placement31$933$29
Flow cytometry technique for dna or cell analysis, 16 or more markers11$916$83
Cell examination of specimen, concentration technique19$409$22
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode12$277$21
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening13$265$20
Pathology examination of tissue using a microscope, limited examination13$57$4

2016: 16 services

Original Medicare services billed in 2016
Evaluation of fine needle aspirate with interpretation and report181$14,372$66
Surgical pathology consultation and report on referred slides prepared elsewhere132$9,805$74
Pathology examination of tissue using a microscope, intermediate complexity222$9,720$36
Special stained specimen slides to examine tissue, each additional procedure65$6,385$25
Cell examination of specimen, selective cellular enhancement technique175$4,702$24
Special stained specimen slides to examine tissue, initial procedure89$3,210$33
Evaluation of fine needle aspirate72$2,867$34
Fine needle aspiration using imaging guidance34$2,338$58
Microscopic genetic analysis of tumor, manual19$1,679$47
Fine needle aspiration biopsy, first growth16$1,087$60
Surgical pathology consultation and report on referred material requiring preparation of slides13$990$76
Ultrasonic guidance for needle placement33$990$30
Special stained specimen slides to identify organisms including interpretation and report21$694$26
Cell examination of specimen, concentration technique18$387$20
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening13$264$20
Special stained specimen slides to examine tissue including interpretation and report15$258$11

2015: 6 services

Original Medicare services billed in 2015
Surgical pathology consultation and report on referred slides prepared elsewhere54$4,374$78
Pathology examination of tissue using a microscope, intermediate complexity50$2,672$36
Evaluation of fine needle aspirate with interpretation and report27$2,054$66
Cell examination of specimen, selective cellular enhancement technique43$1,118$26
Special stained specimen slides to examine tissue, each additional procedure17$1,031$20
Special stained specimen slides to examine tissue, initial procedure21$733$33

Medicaid work

$12,647 in 2024

Medicaid paid $12,647 for 281 billed services this clinician did in 2024, up to 29 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
TISSUE EXAM BY PATHOLOGIST173$6,955
TISSUE EXAM BY PATHOLOGIST27$3,105
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal53$1,317
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure28$1,270
Medicaid work by year
2024281429$12,647
2023148120$8,441
2022245435$11,566
2021410643$19,065
2020112325$6,640
2019123319$3,772
2018128320$4,284
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
TISSUE EXAM BY PATHOLOGIST148$8,441

2022

Largest Medicaid services in 2022
TISSUE EXAM BY PATHOLOGIST192$8,557
TISSUE EXAM BY PATHOLOGIST19$1,613
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure20$1,096
IN SITU HYBRIDIZATION 1ST PROBE STAIN14$299

2021

Largest Medicaid services in 2021
TISSUE EXAM BY PATHOLOGIST220$10,049
TISSUE EXAM BY PATHOLOGIST29$4,349
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure69$2,935
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal67$1,201
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT13$344
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site12$187

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST85$4,591
TISSUE EXAM BY PATHOLOGIST15$1,523
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT12$527

2019

Largest Medicaid services in 2019
TISSUE EXAM BY PATHOLOGIST95$2,954
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT14$606
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal14$211

2018

Largest Medicaid services in 2018
TISSUE EXAM BY PATHOLOGIST89$3,407
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT25$599
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal14$277

Money from drug and device companies

$7,480 in 2020

Industry payments by year
202014$7,480$7,480
2019111$26,400$26,400

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Boston ScientificClinical Trial Product$7,480
4 payments
  • Consulting for Clinical Trial Product · 2020-03-18 · $990
  • Consulting for Clinical Trial Product · 2020-03-18 · $770
  • Consulting for Clinical Trial Product · 2020-02-19 · $990
  • Consulting for Clinical Trial Product · 2020-01-15 · $4,730
See all 4 published payments
Every published payment
Boston ScientificConsulting · 2020-03-18Clinical Trial Product$990
Boston ScientificConsulting · 2020-03-18Clinical Trial Product$770
Boston ScientificConsulting · 2020-02-19Clinical Trial Product$990
Boston ScientificConsulting · 2020-01-15Clinical Trial Product$4,730
See earlier years (2019)

2019: $26,400

Payments by company in 2019
Boston ScientificClinical Trial Product$26,400
11 payments
  • Consulting for Clinical Trial Product · 2019-12-04 · $2,090
  • Consulting for Clinical Trial Product · 2019-11-19 · $4,620
  • Consulting for Clinical Trial Product · 2019-11-12 · $2,090
  • Consulting for Clinical Trial Product · 2019-10-16 · $3,080
  • Consulting for Clinical Trial Product · 2019-10-02 · $1,760
  • Consulting for Clinical Trial Product · 2019-08-28 · $1,870
  • Consulting for Clinical Trial Product · 2019-07-24 · $2,310
  • Consulting for Clinical Trial Product · 2019-06-12 · $2,200
  • Consulting for Clinical Trial Product · 2019-05-14 · $1,540
  • Consulting for Clinical Trial Product · 2019-05-01 · $2,200
  • Consulting for Clinical Trial Product · 2019-04-10 · $2,640

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Cytyc Corporation · Mona Lisa Touch · 2019This clinician$9,475

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1932457264
Licence
CA A136668, MA 247983California A136668: Current · expires 2028-09-30
Trained
Tufts University School of Medicine, 2011 · 15 years ago
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZC0500X (207ZC0500X); Federal specialty code 207ZP0101X (207ZP0101X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2012-08-16
NPI last updated
2024-03-18
NPI record certified
2024-03-18

This is when the NPI record was last certified, not a medical board exam.